Target Price | CHF101.11 |
Price | CHF98.04 |
Potential | 3.13% |
Number of Estimates | 19 |
19 Analysts have issued a price target Novartis 2025 . The average Novartis target price is CHF101.11. This is 3.13% higher than the current stock price. The highest price target is CHF114.84 17.13% , the lowest is CHF84.88 13.43% . | |
A rating was issued by 25 analysts: 4 Analysts recommend Novartis to buy, 19 to hold and 2 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the Novartis stock has an average upside potential 2025 of 3.13% . Most analysts recommend the Novartis stock at Hold. |
20 Analysts have issued a sales forecast Novartis 2024 . The average Novartis sales estimate is CHF42.2b . This is 0.09% lower than the revenue of the last 12 months(TTM). The highest sales forecast is CHF43.0b 1.92% , the lowest is CHF41.3b 2.20% .
This results in the following potential growth metrics:
2023 | CHF40.8b | 1.30% |
---|---|---|
2024 | CHF42.2b | 3.26% |
2025 | CHF44.1b | 4.67% |
2026 | CHF44.9b | 1.84% |
2027 | CHF45.6b | 1.41% |
2028 | CHF46.2b | 1.41% |
16 Analysts have issued an Novartis EBITDA forecast 2024. The average Novartis EBITDA estimate is CHF16.9b . This is 9.05% lower than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is CHF18.3b 1.37% , the lowest is CHF15.9b 14.45% .
This results in the following potential growth metrics and future EBITDA Margins:
2023 | CHF18.1b | 11.03% |
---|---|---|
2024 | CHF16.9b | 6.80% |
2025 | CHF18.0b | 6.76% |
2026 | CHF18.4b | 2.34% |
2027 | CHF19.7b | 7.07% |
2028 | CHF20.0b | 1.52% |
2023 | 44.33% | 9.60% |
---|---|---|
2024 | 40.01% | 9.75% |
2025 | 40.81% | 2.00% |
2026 | 41.01% | 0.49% |
2027 | 43.30% | 5.58% |
2028 | 43.35% | 0.12% |
13 Novartis Analysts have issued a net profit forecast 2024. The average Novartis net profit estimate is CHF9.6b . This is 32.54% lower than the net profit for the last 12 months(TTM). The highest net profit forecast is CHF10.6b 25.54% , the lowest is CHF7.7b 45.48% .
This results in the following potential growth metrics and future Net Margins:
2023 | CHF13.0b | 110.82% |
---|---|---|
2024 | CHF9.6b | 26.35% |
2025 | CHF10.9b | 13.22% |
2026 | CHF11.5b | 5.93% |
2027 | CHF11.9b | 3.89% |
2028 | CHF13.5b | 12.87% |
2023 | 31.88% | 108.11% |
---|---|---|
2024 | 22.74% | 28.67% |
2025 | 24.60% | 8.18% |
2026 | 25.59% | 4.02% |
2027 | 26.21% | 2.42% |
2028 | 29.17% | 11.29% |
13 Analysts have issued a Novartis forecast for earnings per share. The average Novartis <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS is CHF4.74 . This is 32.48% lower than earnings per share in the financial year 2023. The highest <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS forecast is CHF5.23 25.50% , the lowest is CHF3.83 45.44% .
This results in the following potential growth metrics and future valuations:
2023 | CHF6.43 | 110.82% |
---|---|---|
2024 | CHF4.74 | 26.28% |
2025 | CHF5.36 | 13.08% |
2026 | CHF5.68 | 5.97% |
2027 | CHF5.90 | 3.87% |
2028 | CHF6.66 | 12.88% |
Current | 13.97 | 46.43% |
---|---|---|
2024 | 20.70 | 48.17% |
2025 | 18.28 | 11.69% |
2026 | 17.26 | 5.58% |
2027 | 16.61 | 3.77% |
2028 | 14.72 | 11.38% |
Based on analysts' sales estimates for 2024, the Novartis stock is valued at an <a href=https://blog.stocksguide.com/knowledge/enterprise-value-sales-simply-explained>EV/Sales of 4.99 and an <a href=https://blog.stocksguide.com/knowledge/price-sales-ratio-simply-explained>P/S ratio of 4.55 .
This results in the following potential growth metrics and future valuations:
Current | 4.99 | 29.27% |
---|---|---|
2024 | 4.99 | 0.00% |
2025 | 4.77 | 4.46% |
2026 | 4.68 | 1.81% |
2027 | 4.62 | 1.39% |
2028 | 4.55 | 1.39% |
Current | 4.54 | 28.31% |
---|---|---|
2024 | 4.55 | 0.09% |
2025 | 4.35 | 4.46% |
2026 | 4.27 | 1.81% |
2027 | 4.21 | 1.39% |
2028 | 4.15 | 1.39% |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.